Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT04579588
Status
Recruiting
Apply to this trial

Conditions

  • Corona Virus Infection
  • Flu Vaccine
  • Immunity

Eligibility Criteria

Sex
ALL
Age
9 Years - 64 Years
Healthy Volunteers
Accepted

Interventions

  • Flu shot — BIOLOGICAL
    All participants will receive a single shot of the flu vaccine

Study Details

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Key Dates

Start date
Oct 29, 2020
Status verified
Nov 2025
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028

Study Design

Enrollment
230 participants (estimated)

Arms

  • Arm: COVID-19 participants
  • Arm: Control participants

Primary Outcome Measure

Testing immunity to the flu vaccine over time [ Time Frame: 1 week ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityPalo AltoCalifornia94304
SNP Center Inquiry
[email protected]
(650) 521-7237

Find similar trials in Palo Alto, CA

By research site
Stanford University· Palo Alto, CA

Related Studies